Is anything in the patent world ever really free? That question anchors a new Clause 8 conversation between host Eli Mazour and Professor Kristen Osenga, a University of Richmond law professor and one of the leading academic voices on standard essential patents. At the center of the discussion is the rise of so-called “royalty-free” technology standards. Osenga’s point is straightforward: “free” often comes with strings attached - particularly for smaller innovators that may be required to cross-license valuable patent rights or accept terms they may later regret. Her main example is the Alliance for Open Media, the tech consortium behind a “royalty-free” video compression standard. The pitch sounds simple: use the standard without paying royalties. But, as Osenga explains, the real question is what companies may be giving up in return - and whether they fully understand the long-term cost of joining. She offers a simple analogy: a store gives away free croissants to get customers in the door. Customers build habits around it. Then one day the sign changes. In Osenga’s view, the same risk exists here. Companies can build products and business models around terms that may not remain as favorable as they first appeared. From there, the discussion broadens into the wider ecosystem of royalty-free standards, cross-licensing organizations, defensive patent pledges, and emerging AI-related IP initiatives. What is driving these arrangements? Collaboration? Public relations? Strategic control? And what, exactly, should companies think through before signing on? As Osenga puts it: “Follow the money … where are these groups making their money? Because it’s probably coming from some other part of their business model.” The episode also covers: * what the pattern of withdrawals from major cross-licensing organizations reveals about how these arrangements play out over time * SEP policy whiplash across US administrations, the Standard Essential Royalties Act (SERA), and where things stand now * the EU’s proposed SEP framework, and why it stalled * the litigation funding debate, including why Osenga founded The Inventors Defense Alliance * the Tillis-Schiff letter to ANSI, China’s push to shape global standards bodies, and the implications for US innovation leadership * why Osenga believes the RESTORE Act is critical to preserving US innovation leadership It is a conversation worth sharing with anyone focused on licensing, standards, or innovation policy. 🎧 Watch the full episode above or listen on your favorite podcast app - and subscribe to the new Clause 8 YouTube channel for bonus content. 📌 Presented by Tradespace - where ideas take flight. Disclaimer This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.voiceofip.com
Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.
Transcript
From the show. Tap a time to play from there.
SPEAKER_00Welcome to Clause 8, the number one podcast on intellectual property, trusted by top in-house counsel, judges, and policymakers worldwide. Hosted by Eli Mazur, we bring you in-depth conversations with the personality-shaping IP. Brought to you by TradeSpace, where ideas take flight. If you enjoy conversations like this, take a moment to subscribe at voiceofip.com and stay connected to the leading voices in IP. Joining us today is Professor Kristin Osenga,
the Associate Dean and Professor at the University of Richmond Law School. A former Federal Circuit Clerk and a founding member of the Inventors' Defense
SPEAKER_00Alliance, Kristin is a leading academic voice for strong property rights. In this episode, we dive into the policy whiplash of SEP licensing. the hidden anti-competitive risks of royalty-free standards like those seen in the Alliance for Open Media, and why she believes the lack of injunctive relief is handing U.S. innovation leadership over to China. We also discuss her perspective on litigation funding and her clear advice for the administration. Pass the Restore Act.
SPEAKER_01Today, we're lucky to be joined by Professor Kristen Ozinga. She's Associate Dean and Professor at the University of Richmond Law School. And as we were just discussing, we actually first met an IP Watchdog SCP Masterclass event. And so we've both been interested in SCPs for a long time, and I'm glad uh we have this conversation uh to discuss that on clause eight but some interesting stuff has happened since so we'll so we'll get into all of that uh but first i want to kind of uh
find out how you became interested in SCPs because it's somewhat of a niche within a niche.
SPEAKER_01So you obviously, actually, we started at the same law firm and you became a professor and then you clerked at the Federal Circuit. But when did you get interested in SCPs?
SPEAKER_02Yeah. So I started my academic career really focused kind of on claim construction and patent eligible subject matter. But at some point I realized there's nothing else to say about patent eligible subject matter or there's everything to say, but I've said it already. And so I also at the same time kind of got the opportunity to start teaching antitrust. And so the natural intersection between patents and antitrust is SEPs or pharma, but I don't pharma.
So so I started getting really interested in it because I started teaching antitrust as well.
SPEAKER_02And so now now it's almost my entire focus. And do you remember like what was happening with the SCPs at that time that kind of
SPEAKER_01drew you in?
SPEAKER_02You know, that was back when IEEE was trying to put in rules that wouldn't allow you to ask for injunctions. And so that's where the DOJ was stepping in and stepping out and stuff like that. So it was like across that period of time where the antitrust enforcement agencies were looking at standard essential patents while IEEE was still doing weird things with respect to standard essential patents. That's kind of where I jumped into the mix.
SPEAKER_01And did you have, you know, I tend to like think about professors as being kind of pro-patent versus like less pro-patent. I guess did you have, like when you decided to become an academic, did you have any views about the patent system as a whole? I guess not about SAPs yet, but I guess kind of. Yeah.
SPEAKER_02Yeah. I mean, I've always been very pro-patent, very strong patent rights. Maybe some of it's from clerking with Judge Lynn, who I always thought was on the right side of a lot of federal circuit disputes about patents. But also, I just I really believe in the patent system. And it's hard to be a patent academic and not believe in the patent system, I think. I don't know. So many of my friends don't believe in the patent system. So, you know, but yeah, no, I've always kind of come in with a strong property rights view.
And I'm guessing in your practice, did you do litigation or... I did a little bit of both.
SPEAKER_02I did a little bit. I was only in private practice for two years. For about the first year, I did patent prosecution. And then the second year, I did a little more litigation.
SPEAKER_01Anything from that, I guess, experience that maybe... kind of informs how you think about patents because obviously you know you meet people who kind of their whole career they do defensive patent litigation and they think the patent trolls are a problem and then you you uh kind of uh meet maybe people who are uh who do more of the enforcement work on behalf of maybe small inventors they have a different view and stuff like that but anything from your experience that kind of informs the way you think about the balance
SPEAKER_02Less about that. I mean, I'll be honest, is doing litigation as a second year associate. I was just reviewing documents. So I didn't really learn much there. But I think what I took away from my time in private practice was how hard inventors work. And how tricky it is to navigate the patent system. And so maybe that made me a little more pro patent is because that first year, I really I mean, I was lucky enough to be flown out to the inventor's headquarters and actually meet the people who had done the things. And so that was really, really cool.
SPEAKER_02But like, it was a lot of work. And so I think I appreciated the patent system for that reason.
SPEAKER_01That's interesting. You were like there in the beginning of a story where they were coming up with invention and it's not as obvious as it might seem at a later point in time to see what they actually did everything to kind of get there. You know, you mentioned, I guess, when you got into the... I started looking at the SCPs and what was going on there with, I guess, less patent-friendly proposals that were on the table. You know, things have, you know, gotten in all kinds of directions since then. I guess maybe you could talk about that,
SPEAKER_01you know, some of the policy debates that have happened with SCPs and where do you think we are now?
SPEAKER_02Yeah. I mean, it's tricky that the tides change with the administration. You know, we had a set of licensing guidelines that were put out by the PTO and the FTC and the DOJ, and it was like very pro pro patent. And then that got taken away and it became a lot less pro patent. And then that's kind of when IEEE started jumping in. And then it swung back with the new Madisonian approach with Megan Delrahame coming in and being like, no, no, licensing is amazing.
SPEAKER_01And that's around the time we met, actually. Yeah. Yeah.
SPEAKER_02Right. And so that was like, you know, a good high time, essentially, for SEPs. And then things may have slipped back a little more. It seems very cyclical, which kind of makes my job a little fun. Not as fun if your life and, you know, your work depends on SEPs. But a lot of fun if all you have to do is write about them. Yeah.
SPEAKER_01Yeah, and I guess maybe for people who know a little bit less about this stuff, you know, the SEPs, these policy statements that I guess the Department of Justice and the USPTO and I think NIST, they would come up with them. And then, as you mentioned, they would draw them a new ones. What was that really about? Like, why was it important for them to have a policy statement on this matter? Because obviously, what was the role? Was it like... we have this policy statement, now judges are going to kind of use that as their guide?
SPEAKER_01Or what was the thinking there? Well, I mean, you know the Federal Circuit doesn't care anything about policy statements. So I think it was helpful, especially from the perspective of the antitrust enforcers, right?
SPEAKER_02Because if we think about standards development, It looks like a cartel from the outside, right? You have all of the big players in a field getting together to create a single technology that everybody's supposed to use. I mean, I'm overstating, obviously, the situation. But that's essentially what standardization looks like to people who don't understand it. And so it makes sense that we'd have the competition authorities say, no, no, it's actually OK with us so long as. And so it's good because the standards that we get are way
better than we would get
SPEAKER_02if it just one company was in charge of anything. So there's a benefit to standardization. But then what do you do? And so that's why these policy statements were important, because if we want innovative companies to participate in standards development. which is the only way we get good stuff, they have to be able to license their patents. And so those policy statements kind of paved the way of it's okay, it's not an antitrust problem if you license your SEPs.
SPEAKER_01Yeah. And you're talking about, I guess, going back to like 1996 when the first patent pools and stuff like that. Yeah.
SPEAKER_02I mean, they're patent pools, but even just SEPs generally look kind of like an antitrust problem if you don't understand them.
SPEAKER_01And maybe... Do you think there are some valid concerns like what you described, you know, all these innovators getting together? Obviously, they want to make as much money as possible. And they get to control the standard.
SPEAKER_02Well, you know, OK, so I actually have written an article about this because I think it is a problem. It's not like the the money guys. for the companies are sitting around in the room trying to figure out how much money can they make, right? Who they send to these standard development technical meetings are the engineers. Right. And so they're not in it. I mean, yes, they want their company to make money and it's good for them. But it's the people sitting in the room deciding on the technology aren't the
SPEAKER_02people who are, you know, in charge of the business generally for the most part. Right. They send in the technologically competent people. So so I'm not I'm not actually worried about what's going on in those rooms. They're just picking the best encoding technology for 6G. Like they're not saying and this will make our company lots of money. Right.
SPEAKER_01I guess, you know, somebody might listen to this and like, come on, these are very sophisticated companies with a lot of resources. They pay those engineers. The engineers kind of know. They're very smart, like you said. They can figure out, like, you know, how the company makes money. You know, I guess what puts you so at ease, I guess.
SPEAKER_02Well, I mean... FRAND, right? So most of the time, these standard development organizations make the companies that submit technology to them agree to FRAND. And FRAND is like set up as a guardrail, right? So for your listeners who may not be FRAND experts, you know, FRAND stands for fair, reasonable, and non-discriminatory. And the idea there is that So what you're telling the standards development organization is if you pick my technology,
SPEAKER_02I promise to license it to anyone who wants to pay me a reasonable price. And so that means you can't gouge your competitors. It means you can't say no to companies you don't like. And so that does kind of like create some guardrails. And I think I think some of the. And so and I agree with that 100 percent. You know, you describe it, but in the real world, we do see like,
you know, we're up to 6G.
SPEAKER_01You know, we're continuing to develop technology. I would say cellular technology is working really well these days. We have smartphones. The companies that implement the technology are doing really well. Some of them have the largest market caps in the world. Then why all this whiplash with the policy? Why not, you know, why isn't everyone on the same page and saying like, all right, this works well, let's kind of embrace it.
SPEAKER_02Well, I have some thoughts. One of the thoughts is just people don't understand standard development organizations. They don't understand Frand. They don't understand patent pools. They view them as collusion. But I think the other part of it, and this is probably a little more cynical, is that in Jonathan Barnett, who is a professor at University of Southern California, wrote this really great article that's basically like – The patent academia is misleading the policymakers,
in particular with respect to SEP and Fran.
SPEAKER_02And it's kind of like, you know, his point is we, the academics, not me personally, but academics in general, the academics we alluded to earlier that don't like the patent system are... And raising these concerns that you're talking about, right? That, oh, these SEPs are bad. It's causing things to be more expensive. And so they're talking about things like patent holdup and royalty stacking and these concepts.
SPEAKER_02And a lot of it's coming out of academia. Right. And so then the policymakers hear it. It sounds very attractive, right? Oh, my God, this is terrible. Big tech is holding up, you know, our technology and charging us high amounts of money to use this technology. On the other hand, I would pay all the money in the world to keep using my phone. I mean, I'd be really sad to not have it. So so I think that it's useful to remind.
SPEAKER_01Whatever the phone is, $1,000 and 1% of the edge goes to... Very little. Very little, yeah.
SPEAKER_02Yeah, like 15% or something. Well, and I think, I mean, not to just keep referencing Jonathan Barnett, but he's an amazing scholar. But one of the things that he's done and a few other patent scholars that are pro-patent and pro-standards have done is like... The increase in the amount of phone, like, yeah, phones used to cost $400, now they cost $1,400, whatever. That's not all related to the standards. It's not about 6G. It's the fact that you have like a 50 gajillion pixel camera too. That's not actually part of 6G.
Like the beneficial aspects and features of the phones are also adding to the price
SPEAKER_02of the phones, not all of the royalties related to standards. What about from the perspective of the companies that are implementing the standards? Do we see these policy debates, I guess, as a way to kind of bring down their costs?
SPEAKER_01Yeah.
SPEAKER_02I mean, right. Every company that wants to stay in business wants to make more money than they spend. Yeah. That's how they stay in business. Right. And so if if your sole business model is making and selling phones, the less you have to pay to make a phone, the more profit you make. Right. So, of course, an implementer company and if that's all they do is make a phone, they're going to want to pay as little as possible.
SPEAKER_02So they can make as much as possible. But that that then like takes away the flip side. Right. Which if you are making the technology that goes into the phone, you'd also like to make as much money as possible. And so you want to charge it as much as you can for them. And so what Fran is supposed to do is kind of find that middle ground that still allows the phone companies to make money, but rewards the innovative companies. So they keep doing research. And so we have 7G, 8G, 9G. I don't know. You know, one thing I guess that comes to mind is that,
you know, SEPs are very complex.
SPEAKER_01You know, even when I talk to patent attorneys who've never dealt with SEPs, it's like, it takes them a while to understand what it is. And we just barely scratched the surface of the complexity. The reality is that, you know, there are thousands of patents that cover a standard. It's not clear... exactly what are the patents. Some of these, I guess, implementer companies say it's not clear what that friend rate
is because most
SPEAKER_01licensing terms are confidential. You never know if you've quite priced out, everything you'll have to do. And the argument I guess you hear from some of these groups is that really the main victims are not the big implementers. These are small, I don't know if you call them mom, father, child, but these smaller companies who are not as sophisticated licensees who don't have these huge legal teams that have SAP specialists and they have
to navigate it.
SPEAKER_01And Is it really fair to them to have to do that?
SPEAKER_02The flip side, right, is that if they're implementing a standard, they don't have to create that technology. They're basically getting a blueprint of how to make a phone that's going to work for everybody. And they had to do no research, no development. All they had to do was just say, plug and play. And so in that respect, they're actually receiving a really huge benefit as a small company to not have to invest in the R&D. So if they're told, hey, in order to do that, you have to pay 15%, really do feel too bad for them because I can assure you
innovative companies are
SPEAKER_02putting a heck of a lot more than 15% into R&D. So I don't feel bad for them, but I come from a very strong, I support SEPs.
SPEAKER_01Yeah, and I guess one thing that kind of brought it to the forefront is, and I guess that's kind of what I've clauseated, because I'm trying to figure out, like, is this a true pain point that's out there? And, you know, I hear anecdotes, but the European proposal, it was based around the idea of, Small and medium sized entities that are supposedly, quote unquote, the victims of the current ecosystem. And I guess what you think about, I don't know how closely followed,
but what did you think about the arguments that were made for that and kind of some
SPEAKER_01of the proposals that came out of that?
SPEAKER_02I think the EU proposal is terrible, just to be clear. With respect to the standard-setting price boards, right? The price-setting board that they had proposed sounded, first of all, a little more like antitrust than FRAND, right? Which allows for open negotiation between the patent owners and the users and the implementers. But the... The biggest problem with the European – well, there's so many problems with the European proposal.
But one of the problems with the European proposal was where the FRAND setting board was going to be cited was in a court that had nothing – no special knowledge
SPEAKER_02of SEPs or FRAND. It's like, hey, random group of judges who know a little bit about patents, you go ahead and set rates.
SPEAKER_01Yeah.
SPEAKER_02That makes no sense. On top of the fact that standard setting rates could be an antitrust problem depending on how it's set. Less likely. But we also had a proposal in the United States around the same time that they wanted to set up a rate setting board, the SARA bill. I can't remember what SARA stands for now. Yeah. So this idea kind of came in.
SPEAKER_01Was that going to be through a judicial system, right? Through the judicial system, but it was going to be a body set forth to set Fran rates.
SPEAKER_02And that just—not a good idea on so many reasons. Yeah.
SPEAKER_01And why?
SPEAKER_02Well, I mean, again, having people who know nothing about rate settings at rates, having it set outside the context of a negotiation. Yeah. Right. The negotiation allows the companies to work together. It's more collaborative than just here's people who don't know who will tell you the price.
SPEAKER_01And, you know, you didn't hear much about that, Bill, I guess.
SPEAKER_02No. Yeah. Thank goodness. Although I was ready to fight it. Yeah.
SPEAKER_01I had papers ready to go. In the Europe, it seemed like something would get over to the finish line and ultimately didn't. Anything about that moment in time about why you think it kind of came together and why it ultimately didn't succeed, I guess, from your vantage point?
SPEAKER_02I'd like to think it was the grassroots efforts of the good people. I think I wrote a couple of op-eds or blog posts about it myself, even about how terrible the European proposal was. Yeah. No, I don't I don't know why exactly it was pulled back. It didn't. Europe does some crazy things. I don't know if I can say that out loud. Out loud for the world.
SPEAKER_01I don't think they would be offended.
SPEAKER_02They're doing something crazy now with the IP red stuff. So the proportionality. They want to import eBay. How can you trust anything Europe wants to do if they want to import eBay? The injunction decision. One thing you started hearing from the last administration when those debates were
SPEAKER_01going on in Europe. And I don't know how they were using that as a basis or what they said. Well, this is what happens when the U.S. doesn't take a leadership role in reining in S&P owners, I guess they'd say. And now we need to take a rule. And that didn't seem to go anywhere. But I guess, you know, I guess you mentioned that bill, but I guess any kind of thoughts about, you know, where we stand now and like, or maybe like even less administration about like,
SPEAKER_01where's this going? You know, we're talking about it was with Plage, but where's this going? I guess. Yeah. Yeah.
SPEAKER_02I, you know, I have no idea where it's going. I do know that a lot of SEP cases are being brought in Europe instead of in the United States, in large part because of the injunction problem that we just alluded to with the eBay. In the United States, it's really hard for SEP owners to get injunctions because of that FRIEND obligation that we talked about. But in Europe, they actually have a kind of a framework. The UK set up this Huawei versus ZTE framework that other jurisdictions have adopted and And you're able to get injunctions.
SPEAKER_02And so as far as losing leadership, you're right that a lot of the SEP cases might be going elsewhere. And then we get into the whole, can they set a global rate, which is a big debate right now. Can a European court or a German court or a Chinese court set the rate that they have to pay for every patent across Europe? all of the jurisdictions in the world, and then they have anti-suit injunctions. It's basically a mess right now. But a lot of the mess is getting moved out of the United States
in large part
SPEAKER_02because we don't like patents and we won't grant injunctions. You mentioned that the current administration, the current, I guess, officials at the DOJ They seem to appreciate standards and the role of strong patterns and kind of
SPEAKER_01promoting innovation. You know, they've given some speeches. Practically, what do you think? You know, they have, let's say, three more years. If that, what advice would you give them about, like, what should they try to do to kind of, you know, help the innovation or help innovation?
SPEAKER_02Yeah. I mean, I have lots of thoughts, but they're doing some of it already. So, you know, like I mentioned, Dina Calle in particular, who's very familiar with standard essential patents, is at the DOJ now. And she's made a number of speeches that are very pro patent, pro SEP kind of speeches. We also have the DOJ has submitted intervening amicus briefs. in particular in an SEP case down in Texas,
SPEAKER_02saying that SEP should get injunctive relief, that they are not barred from it. They cited one of my papers in that brief, so I was a little bit excited about that. It's kind of weird to see your name just like pop up in a court docket kind of situation on a brief that you didn't write or had anything to do with. So we see some of the actors in the administration doing... outwardly projecting the idea that SEP should be treated well in the United States.
SPEAKER_02They should get injunctive relief. They should be respected. Can they do more? I don't know. Well, I guess my question is doing something that lasts beyond this administration. Well, that would require laws. And I don't think I mean, we've had the three main patent bills sitting in Congress for the last however many years.
SPEAKER_01And you're talking about the prevail, PTAB, PARA 101 and restore it.
SPEAKER_02Yeah. Yeah. Yeah. I mean, we've we've been waiting for one of those good bills to come out for years. I don't think we're all of a sudden going to get it. And standards to kind of bill.
SPEAKER_01Yeah. And I could probably guess answer, but is there one that you think the administration should prioritize?
SPEAKER_02Oh, 100%. I think if restore was ever to pass, we wouldn't have as much to talk about.
SPEAKER_01Yeah.
SPEAKER_02So, yeah.
SPEAKER_01That's the introduction bill. And, you know, I think Cook Morgan Stewart, actually, before she became the deputy director, she did... read an article predicting that this administration would get more involved in some of the legislative efforts. So I guess it remains to be seen. I don't know if you've heard anything interesting on that front.
SPEAKER_02I haven't heard anything interesting on that front. I mean, the administration does seem to be a little more pro-patent, more with respect to para, or patent eligibility at least. But... I think part of the problem is that like the restore bill really isn't about the patent office. Right. The restore bill is a court problem that Congress needs to fix. So, I mean, that'd be great if the PTO is like, yeah, yeah, go go injunctions. But I don't think that carries as much weight as the PTO
saying, let's go patent eligibility.
SPEAKER_01Yeah. So. And, well, Nick Madich actually hosted a panel about Restore. I think he's very pro-Restore X. I'm a big fan of Nick's, too. So, you know, one of the things I guess I wanted to discuss with you is, you know, you recently wrote an article about something called the Alliance for Open Media, which is really, you know, This group, mostly of big tech companies where they're offering free,
SPEAKER_01I guess, free patent rights, free licensing as an alternative for like a video compression technology, which sounds great to me, you know, a free alternative that all these big companies invested in. What's the issue with that? Yeah.
SPEAKER_02Oh, boy. There's no such thing as a free lunch, right? There's no such thing as a free standard either. I mean, maybe there are a few free standards. But so the Alliance for Open Media, super interesting. They've developed some standards. It's all your big players. It's Netflix, Google, et cetera. So super interesting group, and they came up with a video encoding standard that Netflix is using, I think, on about 95 percent of its programming,
SPEAKER_02among others, like other groups are using it, too. But Netflix is a heavy user of this standard. So the... The way that the standard is being offered is royalty free, which you hear free and you're like, the problem with royalty free is what do they get out of it? And so the way this works is if you want to use my standard, you don't have to pay me. So this is different than the friend. Right. But if you want to use my standard, you have to agree to license back to me any relevant technology
you have patented.
SPEAKER_02So that's great if you're you and me. I mean, well, maybe you have patents, but I don't. So so if I wanted to implement and I don't have patents, royalty free might be kind of cool. But the real problem is, is we have small innovative companies that maybe have five or six patents, some of them, most of all of them related to videos. Right. And they want to use this video encoding technology on their device. They would then have to agree to AOM to say, yes, and you can use my five patents for free,
too.
SPEAKER_02So say Netflix has thousands of patents. Some of them are incorporated in the standard. Netflix is giving you a small, small portion of their portfolio for free, but they're free to make money else wise. The small company that has five video patents and now has to license them royalty free to AOM now is making no money on their patents. So that's not free anymore because now for them to make money, those small companies that want to use AOM standards on their devices,
they're going to have to start charging you more because they're not making revenue
SPEAKER_02anymore from licensing their patents.
SPEAKER_01You know, take a step back, I guess, you know, what do you think motivated Netflix and these other companies to come up with their own video compression technology? Because obviously other companies kind of focused on that have come up with technology. What do you think kind of motivated that in it?
SPEAKER_02Well, I mean, presumably it's a really good standard. I mean, I like watching shows on Netflix, so I'm assuming it's really good. So, you know, I think sometimes when we're thinking about standards, we're sometimes thinking, oh, what's the nefarious purpose? What do they get out of it? I think sometimes they're just trying to solve a technological problem. That they didn't think was being solved. Or that they could do better, right? And so I think that that's... And I don't know any different from that, right? I have no reason to believe that this standard was developed
for any nefarious reason. I think it's just they decided, hey, let's come up with a really great way to encode video.
SPEAKER_02Now, then when they decided how to license it to other companies, that's where things got into the rub.
SPEAKER_01So, you know, obviously there might be some small companies out there who have those five patterns, but I imagine there's way more small companies who don't have any patterns, who wouldn't even know where to start, kind of coming up with this technology, have the resources to do it. You know, what's... What's the harm? Yeah, yeah.
SPEAKER_02So, I mean, first of all, there's no guarantee it'll always be free. Right. It's royalty free today. And they could change their mind at any time and say, oh, nope, sorry. Starting, you know, January 1, you're going to have to start charging it for us. The problem then is that the small companies have invested in building everything around this standard. So it's kind of like a... You know, when a new store opens, they're like, come in and get a free croissant to get you sucked into it. I mean, that's a silly example,
but there's no guarantee these royalty-free patents stay free.
SPEAKER_01Oh, so the license doesn't guarantee... Forever, right.
SPEAKER_02So there's nothing saying that AOM couldn't say, okay, now it's a million dollars for you to use our encoding technology. And that's one of the things that... Dina Kelly mentioned also in her speech is kind of like royalty free doesn't mean free forever either, even if it's not implicating your own patents. So I guess what is like the practical, I guess, what would you like to see?
SPEAKER_01Or actually, before we get into that point, like one of these small companies, now they're deciding we're going to use video compression technology. What should we use? What recommendations would you provide to them about how we should navigate, I guess, the current?
SPEAKER_02Well, you know, I mean, it's tough, right? Because if you if you're, for example, coming up with a new smart TV or something and it doesn't show Netflix films, who's going to buy your TV? Right. So you don't. The problem is, is because Netflix has such an incredible catalog. You don't want to turn them down. Right. And so there's there is a concern and it's definitely something that has come up when we have content providers and platforms.
SPEAKER_02And Netflix isn't quite like that. But if we have a content provider that then also is heavily invested in a standard.
SPEAKER_01Yeah. And this actually got this raised a question during the most recent hearings for
SPEAKER_02the Netflix Warner Brothers merger. Right. One of the senators asked, like, what is the deal with this licensing situation and what does that mean? That fell through and Paramount and whatever. But that was that was a real concern during that time, because if you think that in order to show Netflix and Warner Brothers the catalog contained by those two companies, you're going to have to engage in this royalty, quote unquote, free licensing agreement. That's a lot.
SPEAKER_02But you can't hardly say no. Yeah.
SPEAKER_01So, yeah. So I guess if a company needs to... If a company needs to implement that standard, they don't have much of a choice now. Right. So what, I guess, what is the solution to this situation?
SPEAKER_02Well, I mean, I wonder, I wonder, and again, I am not in charge, but I wonder if there really needs to be a look into these royalty-free I mean, FRAND has been for multiple administrations blessed by the DOJ and FTC antitrust enforcement, specifically the DOJ. They care more about this, it seems, than the FTC. But I wonder if the DOJ were to take a closer look at the anti-competitive effects
SPEAKER_02of royalty free and maybe encourage, no, FRAND is actually more competitive. Yeah. Because then you can opt to pay and small companies that only have five patents can opt to pay knowing that it's a cost of business. Right. Without losing their ability to make revenue from anybody.
SPEAKER_01Yeah. And I imagine there is alternative technology. Yeah. Yeah. You're driving them out of business and then you could stop investing in the technology.
SPEAKER_02You know, money is a lot easier to be competitive with.
SPEAKER_01Yeah. than restricting access yeah so i i think that that that would be my my you know i i don't know that there's a solution but i do think that one solution would be assessing the anti-competitive nature of royalty free and this is not exactly the same but i i guess when you were discussing you kind of hear a lot of these kinds of agreements or these organizations where companies are asked to, um, you know, pledge that they won't enforce their patents.
SPEAKER_01Uh, a lot of network comes to mind. I know open invention network is another one. Um, but you're hearing now there's kind of talk about companies plaguing that they won't force their patents in the AI space and for fundamental technologies. Um, You've been following it for a while. I don't... Just to me, it's kind of maybe... Maybe it's not that different than it always was, but what's driving this? What's the fundamental kind of reasons for these groups and
asking for these kind
SPEAKER_01of commitments? What's the...
SPEAKER_02You know, I mean, it's such a cliche answer, but my suggestion in any of those cases is follow the money. Like, where are these groups making their money? I mean, I think, if I'm remembering correctly, right, didn't Elon Musk offer electric car patents for free? Didn't he say he wasn't going to enforce Tesla's patents, right? But he was still making money hand over fist. So where was the money coming from? It was like... It was the sales. He didn't think anybody was going to be able to compete with Tesla's cars. And so I wonder what,
with these various organizations that are pledging not to enforce their patents,
SPEAKER_02where's their money coming from? And that it's probably coming from some other part of their business model that may be very similar to the, like, well, once we get you locked into the free standard, we're going to start charging you. Once you start building your cars using Tesla's patents, and all of a sudden we change our minds, like... What's who's enforcing the pledge?
SPEAKER_03Yeah.
SPEAKER_02Right. Like there's no contract out there that Elon Musk is like, I promise forever. And if I break this, you can sue me like.
SPEAKER_01And I guess, you know, it seems like, you know, obviously when companies join one of these groups or something or make agreement, they put out a press release and they're like, we're the good guys. We're joining the good guys. And other companies see that and start thinking about. Oh, should we do that as well? What's the harm, I guess? Any advice to them about how they should think through joining or not joining these groups?
SPEAKER_02I mean, there's a lot of ways to virtue signal if you're a company. I don't know if giving my patents away would be the way I would choose to do it. So, I mean, find a different way to make yourself look good. Well, I guess my question is, is there a possible benefit to joining one of these groups?
SPEAKER_01Yeah.
SPEAKER_02I mean, I don't know the details of all the various groups. I don't imagine they get as much out of it as they expect they're going to. I mean, are they getting a little publicity? Are they getting a little, like, some forms? Like, what are they getting out of it?
SPEAKER_01I mean, one thing, I guess, with LOT, which I think is one of the bigger groups, I guess one thing you see is that before, I guess they have rules about companies being able to withdraw from that, and right before they withdraw... I guess there's a spike in their membership because that's the last chance to get like the patent rights of the company that is about to withdraw. So there's an interesting dynamic there. Obviously, it's not good for the company that's withdrawing.
SPEAKER_02Not good at all. That would be a big, big red flag. Yeah.
SPEAKER_01I mean, another thing that you see is obvious. I think two examples that stand to mind with that is Broadcom, they acquired VMware. And then they wanted to withdraw VMware, and then HP acquired Juniper, and they wanted to withdraw Juniper. And, you know, it's like somebody else is reviewing now their decisions they made, and they're coming to a different, I guess. yeah well i mean that's exactly what i was thinking when you
were saying that i'm like well if you look at the smart companies that are still in business and making lots of money they're withdrawing yeah so that that ought to tell you what you need to know right there right i'd rather be an hp than a juniper so you gotta you gotta be uh i guess careful about what you sign sign up for you know part of it you know you mentioned uh elon musk obviously uh but other companies you know before them
SPEAKER_01you know goes back to uh I don't know if you remember, but Twitter, they made a big splash about their, I think it was called, I forget. They had some kind of like, innovators patent agreement or whatever, where they promised to the inventors within their company that they wouldn't enforce their patents until like some particular situations. And actually, I thought that kind of went away, but actually I was looking at OpenAI's website and it said
something like,
SPEAKER_01we pledge to only use our patents defensively, so long as a party does not threaten or assert a claim, initiate a proceeding, help someone else, blah, blah, blah. And it seems like, you know, I think you called it virtue signaling. So they got virtue signaling is, you know, I don't know how many engineers there are at, or AI scientists, I don't know what you call it. And it opened it, and we're like worried about how the patents is, but it seems like that's kind of a, uh, Still the ethos of, I guess, large companies in at least Silicon Valley.
SPEAKER_01What do you think it says about the patent system? Or what do you think it says about the views? Well, I mean, I think actually I don't have a problem with defensive patent use.
SPEAKER_02I think that that's actually the patent system working well. Yeah. Right. Because that's it's just providing a currency on which to negotiate in the open market. Right. You can sue me and it will cost lots of money and we will go to court and that will be amazing. Or you can approach me and say, I'm going to sue you. And I'll say, well, great, I'll sue you back.
SPEAKER_01Yeah.
SPEAKER_02And then we say, OK, let's cross license instead. Yeah. Right. That's actually a really good outcome of the patent system. So I don't actually have a problem.
SPEAKER_01Don't you think it sends a signal? Well, actually, enforcing patents is not a good thing. That's why we're pledging not to.
SPEAKER_02Well, I don't I think what they're actually saying. I mean, I don't actually think what I don't know what they're actually saying, but I will say, you know, it's risky business to enforce a patent nowadays. Right. If you have a patent and you do sue somebody on it, it's going to be challenged. It's validity. You know, it's going to be oftentimes brought into both the PTAB and district court at the same time. So you have multiple tracks of suits that you have to defend against. It's expensive. Right. And so if you actually just gather up the patents and sit back.
SPEAKER_02And use it defensively. Your patents aren't getting challenged while you're sitting there just holding them, but you're keeping away the lawsuits. And I don't think it's because enforcement itself is naturally bad. I think it's just enforcement is risky for patent holders and you don't end up with an injunction anyway. So there's that.
SPEAKER_01You know, I, as we said, you know, lots of things happen. One of the things I guess that's probably happened in the, since we met, is the rise of litigation funding. Yeah. And you actually helped start a group called the Inventors Defense Alliance, which is pro-litigation funding. Yeah. Can you talk about what made you interested in that enough to want to start a group around that? And I guess...
SPEAKER_02Yeah. Yeah. I mean, so so litigation funding, I believe, is super important for small and medium companies. There's the tale is at least right that you have a lot of big tech suing little company or big tech infringing little companies patents. Right. And if a little company is going to bring an infringement lawsuit, it's expensive. Right. And a big company has the pockets to kind of wait it out.
SPEAKER_02It's like a siege. Right. And so they can just file discovery requests and they can file PTAB actions. And, you know, the big company, the defendant, all the while while they're infringing and the little company may not be able to financially withstand that. And so the way around that is litigation funding. And so I kind of got involved in it because there started being talk of bills being brought up. There's the ISA bill. There's the Tillis bill. So there's a bunch of where they want disclosure. We have Judge Connolly over in Delaware saying,
disclose all your funders to me.
SPEAKER_02And so all of those things make it very important. risky or impossible for small and medium companies to get money to bring lawsuits to defend against infringement. And as somebody who loves strong patent rights, if you can't enforce your patent rights, you have no patent rights. And so that's that's why I care about litigation funding.
SPEAKER_01But what's the big deal with disclosing the funding, you know? Judge Conley just wants to know there's nothing nefarious going on.
SPEAKER_02Yeah, well, no. Judge Conley, no. Judge Conley himself, I believe, has said it's patent trolls, which I just fully don't understand. But that's neither here nor there. So there are two big problems with funding, right? First of all, if you are disclosing your funders, it depends on how the bills or local rules or whatever are written. But you could be disclosing down to the individual human, like any person who stands to benefit from this litigation. And say you have like CalPERS or whatever, right?
SPEAKER_02The California police or teachers or whatever. Cal teachers. I can't remember. Anyway, but like you have a lot of big state funds. public employee funds, that some of them engage in, among other things, risk diversification, litigation funding. Are you going to disclose Ms. Sally Smith, who's 88 years old and taught for the school district for 50? Like, no, you don't want to disclose Sally Smith, right? And because of disclosure rules that are written so very broadly that it could
SPEAKER_02require that level of disclosure, it's going to scare away your funders. Right. CalPERS isn't going to get involved anymore in funding litigation if they know they're going to have to give out their roles of retirees. So that's one. But more nefarious in my mind, that's pretty nefarious to get Sally Smith's name. But, you know, more nefarious in my mind is even if you don't have to disclose that level of funder, you oftentimes have to disclose the amount of funding. Right.
And so what you're doing there is you're giving the big company who is prepared to
SPEAKER_02engage in a siege a goalpost. You just have to get them to spend $10 million. And once they spend that $10 million of funding... They're out of money. Right. Or one million or ten thousand. Like it doesn't matter. Right. All you have to do what you're doing by forcing a disclosure of the funding agreement is you're giving the defendant. You just have to reach this line in the sand and they are out of money.
SPEAKER_01Yeah.
SPEAKER_02And that's just like, OK, game plan. Ready to go. I can make them spend that much money. Discovery request. Discovery request. PTAB.
SPEAKER_01And we'll go, there's obviously lots of different proposals and compromises, but do you have any concerns about litigation funding? Like, you know, I guess, but from what I understand, you know, at least you hear is that Porn entities can, you know, secretly fund lawsuits against American companies and you'd never know who it is and bankrupt their, you know, whatever, you know.
SPEAKER_02Oh, so no, that's not the worst story I've heard. The worst story I've heard is that Chinese companies will fund litigation in order to get access to American trade secrets.
SPEAKER_01Yes, yes, yes, that's the number.
SPEAKER_02Tell me how that's going to happen. You know, in general, funders have no access to the underlying substance. In any case that has trade secrets involved, there's protective orders. Like, that's the silliest story. And there's no evidence that that's a problem. Like, that's a problem in search of truth.
SPEAKER_01Yeah. I just, you know, obviously— Adam, too much litigation is not good, right? Sure. And do you have any concerns about, and maybe do you see funding for patent litigation maybe different from some other areas, but do you have any concern if it's about litigation funding and the growth? Right.
SPEAKER_02Growth of it. Well, OK, so I actually don't have a problem with litigation, to be honest. Right. Because in America. Right. Patents. Well, in anywhere. But let's focus on America. Right. In America, all the patent gets you is exclusive rights.
SPEAKER_01Yeah. And if you can't get them to stop infringing by asking them nicely, you have to litigate. And if you can't litigate and you can't stop them from doing it, your patent is valueless. And again, going back to the beginning of our conversation, strong patents.
SPEAKER_02So if you can't enforce. So I don't have a problem with litigation necessarily as existing. And if you think about like, wait a second, litigation fund is going to litigation funding is going to lead to lots of frivolous litigation. Too many suits. Litigation funders are in it to make money. Right. They're not going to fund a frivolous suit because they don't want to lose the money they put in. And it's hard to get information about litigation funding. But like the the the numbers I've heard rumbling around is like
less than somewhere
SPEAKER_02between one and five percent of litigation funding requests are granted.
SPEAKER_01Yeah.
SPEAKER_02Most cases are like, yeah, no, take a hike. I'm not funding that.
SPEAKER_01Actually, we recorded an episode today where the guest was telling us about how difficult and ultimately unsuccessful he was with getting litigation funding. Right.
SPEAKER_02See?
SPEAKER_01And you hear that a lot. But I guess it doesn't seem like you have concerns.
SPEAKER_02I have. I have so little concern.
SPEAKER_01But do you think, you know, you hear about all kinds of compromises to address the issues that you're saying, like, maybe just disclose it to the judge or disclose something? Do you think there's some kind of compromise that could be reached or any of the legislation that sticks out to you that you think is- I mean,
SPEAKER_02I think, okay, I think what you need to first do is tell me what problem you're really trying to solve, right? So if you're trying to solve the China problem, then maybe you narrowly tailor the bill to say you need to disclose any foreign companies that are invested in the funding, right? That's it. Not the goalposts at the end of the line, not how much money the agreement is, but just if your only concern about litigation funding is China, then you have to tell. Now, some of this is already taken care of with another a number of
international
SPEAKER_02security bills and stuff like that. But that would be one way to tailor if you're worried about. Conflicts with the judges, that's another thing that Judge Connolly has said, oh, I'm so concerned about conflicts. Sure. Whatever, Judge Connolly. OK. But if you're so concerned, right, then maybe it's disclosing the high level of funders to the judge alone. Right. He doesn't need to know Sally Smith because he's not invested in Sally Smith, but maybe he's invested in CalPERS. I don't know. So that would be a way to solve if that's your problem.
SPEAKER_02Right. If the judge is concerned about conflicts, it doesn't need to be disclosed to the other party. The endpoint doesn't need to be disclosed. Yeah. That to me is just more of the season goalpost level. Right. Like, OK, now if we know how much funding you have now, we know. Do they need to get the funders involved in the settlement conferences?
SPEAKER_02I know less about that end of it. But I really feel like if that's your main beef, then disclosure doesn't. Disclosure doesn't solve that problem. That's a different problem to be solved. And I'm not sure how to solve the settlement concerns. Some of the opponents of litigation funding just are opposed to litigation taking place.
SPEAKER_01But others, you know, I think they're trying to get some of these issues. You know, I've heard of this like Kansas compromise or whatever. Are any of the bills that you're hearing, you know, in Congress that you think are getting close to what?
SPEAKER_02No. No. I don't think any of them strike the right compromise. And I think the reason is, is because I still have yet to hear a unified answer of the problem we're trying to solve.
SPEAKER_01Yeah.
SPEAKER_02And if you're trying to solve China and conflicts and settlements. I'm not sure where your compromise is.
SPEAKER_01Well, I'm just going to say all of those are problems. But the foreign funding is the one I do hear more, I guess, I hear the most about it. More loudly. Because I think that's kind of a very compelling... for people who don't know much.
SPEAKER_02They don't realize that there's protective orders.
SPEAKER_01Even if I heard, you know, if they name a foreign country, which I think is evil, I'm like, yeah, they shouldn't be allowed to foreign fund. But, you know, that's, I guess that's kind of goes to probably investing in America in general. So I think that's maybe more than that. You know, we have to kind of maybe circle back to SCP stuff. I don't know if you saw the letter that Senator Tillis and Schiff recently sent to ANSI about their concern about some of the conflicts of interests
SPEAKER_01and transparency with some of the, I guess, groups that are involved in standard bodies. The letter itself wasn't kind of a... Didn't describe everything perfectly. But I guess, can you, I guess, what's your impressions, I guess, and if you get a chance to see that letter or these issues in general?
SPEAKER_02I mean, I've seen the letter. I think some of the concern with Sanders' bodies is, again, America is losing some of its leadership. Yeah. Or flip side, right? Actually, I'm going to go a positive direction in another way, right? Like China has the China 2025, 2035, where we will be leaders in standards bodies. We will be. And it's like we don't have that and nor am I ever going to
suggest that we should
SPEAKER_02turn into China. And we don't want government-sponsored innovation, I don't think.
SPEAKER_01Yeah. Yeah.
SPEAKER_02I wouldn't go there. But we don't have a country that values innovation. And so I think that that's some of what's being reflected in the we are concerned about standards bodies is really the idea of China is particularly intentionally going out and trying to become leaders in standards bodies. Yeah. Whereas America is saying, if you get a patent and you're in a standard, we're not even going to give you an injunction. Right. And so that's not exactly what Schiff and Tillis said in their letter.
But but I think the underlying concern about transparency and conflicts of interest
SPEAKER_02and standards, a lot of it has to do with we're no longer the boss of innovation. And and I think they're rightly concerned in that space. And particularly because China has intentionally wanted to insert themselves into the leadership of standards bodies. Boy, we're falling behind. Yeah.
SPEAKER_01And I think we agree nobody wants America to become China.
SPEAKER_02Yeah, just to be clear, I want to say that one more time. I'm not saying that. But what do you think the administration or government can do to kind of make sure
SPEAKER_01that America remains the leader in— Pass the restore bill? Yeah.
SPEAKER_02That's my answer. Anytime somebody's like, how can we fix? I'm like, pass the restore bill. So that's, so I think, as we discussed, that is pretty clear advice right there.
SPEAKER_01You know, you know, I want to kind of, any other thoughts, you know, about the PEN policy, PEN system, about where things are, or any final thoughts for the Closet audience? Yeah.
SPEAKER_02Pass the restore bill. No, I think a lot of people are putting a lot of thought into how can we make the patent system work for American companies, which as an American-centric person, that works for me. That framing works for me. And I really do think it comes down to we need a patent system that respects innovation and a patent system that is predictable. And not predictable in the you will never get an injunction
kind of way of
SPEAKER_02predictability, but rather like you have a patent, you're going to be able to stop people from using it. You invented something in these technology fields, you are going to get a patent. Right. I think that the unpredictability that we've seen over the last number of years is really weakening our patent system and it's driving people elsewhere. And that's that sucks. Sobering thought to end on, but I think... You asked for my party advice. Okay, I'll put it on that better note. Pass the restore bill.
SPEAKER_01Well, from your ears to, I guess, Congress's way again. Well, thank you so much for coming on Closade.
SPEAKER_02Thank you for having me.
SPEAKER_00Thank you so much for listening. New episodes of Clause 8 come out every two weeks, so be sure not to miss them by subscribing at voiceofip.com or wherever you listen to podcasts. And if you enjoy Clause 8, please leave us a five-star rating to help others find the show.
Austin Walters saw the AI boom coming as an inventor on more than 650 patents. Now the IP Copilot founder explains how companies lose most of what their engineers invent. He spent two years at a major patent filer...
Perry Saidman passed away on October 15, 2026, less than a month after we recorded this conversation. Perry built the market for design patents. His win in Avia v. LA Gear, a sneaker knockoff case, helped prove design...
When Coke Morgan Stewart became acting director of the USPTO, much of the patent world knew little about her. In this episode of Clause 8, Stewart, now President and CEO of the Council for Innovation Promotion (C4IP),...
To open the season, host Eli Mazour brings together three journalists who cover intellectual property for a living: Olivia Rafferty of IP Fray, Nisha Shetty of IAM, and Inbar Preiss of MLex. They discuss what happens...
Kevin Mack, the new president of Via Licensing Alliance, joins Eli for the Clause 8 season finale. Kevin talks about Via's plans to build its next patent pools around "de facto" standards - technology the market adopted...